ABX464 is primarily investigated for its potential therapeutic applications in treating inflammatory diseases and viral infections. It has shown promise in modulating the immune response, particularly in conditions like ulcerative colitis, where it helps reduce inflammation and promote mucosal healing. Additionally, ABX464 is being studied for its antiviral properties, especially in the context of HIV, as it may enhance the splicing of viral RNA, leading to the production of defective viral particles and reducing viral replication. Its dual role in addressing both inflammatory and viral conditions makes it a compound of significant interest in medical research and drug development.